Royce & Associates LP Has $11.23 Million Holdings in Teleflex Incorporated $TFX

Royce & Associates LP lifted its holdings in Teleflex Incorporated (NYSE:TFX) by 31.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 92,030 shares of the medical technology company’s stock after acquiring an additional 22,030 shares during the quarter. Royce & Associates LP’s holdings in Teleflex were worth $11,231,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of TFX. AQR Capital Management LLC boosted its holdings in shares of Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after acquiring an additional 1,956,811 shares in the last quarter. Abrams Bison Investments LLC acquired a new position in shares of Teleflex in the 3rd quarter worth approximately $112,317,000. Thrivent Financial for Lutherans boosted its holdings in shares of Teleflex by 1,161.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock worth $67,353,000 after acquiring an additional 506,796 shares in the last quarter. Capital International Investors acquired a new position in shares of Teleflex in the 3rd quarter worth approximately $44,851,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Teleflex by 123.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock worth $80,855,000 after acquiring an additional 365,663 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on TFX shares. Wells Fargo & Company boosted their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Mizuho set a $140.00 price objective on Teleflex in a report on Friday, May 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Needham & Company LLC upped their price objective on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $144.00.

Teleflex Stock Performance

Shares of Teleflex stock opened at $130.21 on Thursday. The firm has a fifty day moving average of $124.04 and a two-hundred day moving average of $117.15. The stock has a market capitalization of $5.76 billion, a price-to-earnings ratio of -5.71, a PEG ratio of 0.98 and a beta of 0.82. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.96%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.